EyePoint Pharmaceuticals (EYPT) Prices 15M Share Common Offering at $1.45/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
After-Hours Stock Movers 02/20: (ZIXI) (EHTH) (DBX) Higher (EYPT) (TRUE) (FSLR) Lower (more...)
February 20, 2020 5:42 PM ESTAfter-Hours Stock Movers
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) 18.5% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering.
TrueCar (NASDAQ: TRUE) 18.2% LOWER; reported Q4 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $89.7 million versus the consensus estimate of $88.05 million. TrueCar sees Q1 2020 revenue of $87-89 million, versus the consensus of $86.92 million. TrueCar sees FY2020 revenue of $335-355 million, versus the consensus of... More
EyePoint Pharmaceuticals (EYPT) to Offer Common Stock
February 20, 2020 4:22 PM ESTEyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by EyePoint. The offering is subject... More
